Sesti G - Search Results

1

Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetes.

Pezzilli S, Mazza T, Scarale MG, Tang Y, Andreozzi F, Baroni MG, Buzzetti R, Cavallo MG, Cossu E, D'Angelo P, De Cosmo S, Lamacchia O, Leonetti F, Morano S, Morviducci L, Penno G, Pozzilli P, Pugliese G, Sesti G, Doria A, Trischitta V, Prudente S. Pezzilli S, et al. Among authors: sesti g. Acta Diabetol. 2022 May;59(5):747-750. doi: 10.1007/s00592-021-01847-y. Epub 2022 Feb 3. Acta Diabetol. 2022. PMID: 35112188 No abstract available.

2

Polymorphisms of the insulin receptor substrate-2 in patients with type 2 diabetes.

D'Alfonso R, Marini MA, Frittitta L, Sorge R, Frontoni S, Porzio O, Mariani LM, Lauro D, Gambardella S, Trischitta V, Federici M, Lauro R, Sesti G. D'Alfonso R, et al. Among authors: sesti g. J Clin Endocrinol Metab. 2003 Jan;88(1):317-22. doi: 10.1210/jc.2002-020807. J Clin Endocrinol Metab. 2003. PMID: 12519871

3

The Gly972-->Arg IRS-1 variant is associated with type 1 diabetes in continental Italy.

Federici M, Petrone A, Porzio O, Bizzarri C, Lauro D, D'Alfonso R, Patera I, Cappa M, Nisticò L, Baroni M, Sesti G, di Mario U, Lauro R, Buzzetti R. Federici M, et al. Among authors: sesti g. Diabetes. 2003 Mar;52(3):887-90. doi: 10.2337/diabetes.52.3.887. Diabetes. 2003. PMID: 12606535

4

Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells.

Andreozzi F, Laratta E, Sciacqua A, Perticone F, Sesti G. Andreozzi F, et al. Among authors: sesti g. Circ Res. 2004 May 14;94(9):1211-8. doi: 10.1161/01.RES.0000126501.34994.96. Epub 2004 Mar 25. Circ Res. 2004. PMID: 15044323

5

The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes.

Sesti G, Marini MA, Cardellini M, Sciacqua A, Frontoni S, Andreozzi F, Irace C, Lauro D, Gnasso A, Federici M, Perticone F, Lauro R. Sesti G, et al. Diabetes Care. 2004 Jun;27(6):1394-8. doi: 10.2337/diacare.27.6.1394. Diabetes Care. 2004. PMID: 15161794

6

The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes.

D'Adamo M, Perego L, Cardellini M, Marini MA, Frontoni S, Andreozzi F, Sciacqua A, Lauro D, Sbraccia P, Federici M, Paganelli M, Pontiroli AE, Lauro R, Perticone F, Folli F, Sesti G. D'Adamo M, et al. Among authors: sesti g. Diabetes. 2004 Jul;53(7):1905-10. doi: 10.2337/diabetes.53.7.1905. Diabetes. 2004. PMID: 15220218

7

Interaction between vascular dysfunction and cardiac mass increases the risk of cardiovascular outcomes in essential hypertension.

Sciacqua A, Scozzafava A, Pujia A, Maio R, Borrello F, Andreozzi F, Vatrano M, Cassano S, Perticone M, Sesti G, Perticone F. Sciacqua A, et al. Among authors: sesti g. Eur Heart J. 2005 May;26(9):921-7. doi: 10.1093/eurheartj/ehi112. Epub 2005 Feb 2. Eur Heart J. 2005. PMID: 15689344

8

C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance.

Cardellini M, Perego L, D'Adamo M, Marini MA, Procopio C, Hribal ML, Andreozzi F, Frontoni S, Giacomelli M, Paganelli M, Pontiroli AE, Lauro R, Folli F, Sesti G. Cardellini M, et al. Among authors: sesti g. Diabetes Care. 2005 Aug;28(8):2007-12. doi: 10.2337/diacare.28.8.2007. Diabetes Care. 2005. PMID: 16043746

9

The functional Q84R polymorphism of mammalian Tribbles homolog TRB3 is associated with insulin resistance and related cardiovascular risk in Caucasians from Italy.

Prudente S, Hribal ML, Flex E, Turchi F, Morini E, De Cosmo S, Bacci S, Tassi V, Cardellini M, Lauro R, Sesti G, Dallapiccola B, Trischitta V. Prudente S, et al. Among authors: sesti g. Diabetes. 2005 Sep;54(9):2807-11. doi: 10.2337/diabetes.54.9.2807. Diabetes. 2005. PMID: 16123373

10

The E23K variant of KCNJ11 encoding the pancreatic beta-cell adenosine 5'-triphosphate-sensitive potassium channel subunit Kir6.2 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes.

Sesti G, Laratta E, Cardellini M, Andreozzi F, Del Guerra S, Irace C, Gnasso A, Grupillo M, Lauro R, Hribal ML, Perticone F, Marchetti P. Sesti G, et al. J Clin Endocrinol Metab. 2006 Jun;91(6):2334-9. doi: 10.1210/jc.2005-2323. Epub 2006 Apr 4. J Clin Endocrinol Metab. 2006. PMID: 16595597

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

488 results

Search Page